These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10194068)

  • 1. Induction of prostaglandin release from macrophages by bacterial endotoxin.
    Offenbacher S; Salvi GE
    Clin Infect Dis; 1999 Mar; 28(3):505-13. PubMed ID: 10194068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.
    Salvi GE; Beck JD; Offenbacher S
    Ann Periodontol; 1998 Jul; 3(1):40-50. PubMed ID: 9722689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients.
    Salvi GE; Yalda B; Collins JG; Jones BH; Smith FW; Arnold RR; Offenbacher S
    J Periodontol; 1997 Feb; 68(2):127-35. PubMed ID: 9058329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontitis and cytokine expression in CD14 deficient patients.
    McNamara KM; Hall SE; Wilder RS; Lawrence HP; Offenbacher S
    J Int Acad Periodontol; 1999 Oct; 1(4):95-100. PubMed ID: 12666953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of a hyperinflammatory prostaglandin E2 response to Porphyromonas gingivalis challenge in severe combined immunodeficient mice.
    Salvi GE; Spets-Happonen S; Singer RE; Offenbacher S
    J Periodontol; 2005 Jan; 76(1):16-21. PubMed ID: 15830633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis.
    Araya AV; Pavez V; Perez C; Gonzalez F; Columbo A; Aguirre A; Schiattino I; Aguillón JC
    Eur Cytokine Netw; 2003; 14(3):128-33. PubMed ID: 14656685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils.
    Kido J; Kido R; Suryono ; Kataoka M; Fagerhol MK; Nagata T
    Oral Microbiol Immunol; 2004 Jun; 19(3):182-7. PubMed ID: 15107070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of epidermal growth factor receptor-dependent signaling by Porphyromonas gingivalis lipopolysaccharide in life-expanded human gingival fibroblasts.
    Quinchia-Rios BH; Guerrero M; Abozeid S; Bainbridge B; Darveau R; Compton T; Bertics PJ
    J Periodontal Res; 2008 Jun; 43(3):290-304. PubMed ID: 18221293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased release of IL-12p70 by monocytes after periodontal therapy.
    Fokkema SJ; Loos BG; de Slegte C; Burger W; Piscaer M; IJzerman Y; Van der Velden U
    J Clin Periodontol; 2003 Dec; 30(12):1091-6. PubMed ID: 15002896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine effects on PGE2 and IL-1 beta release by LPS-treated human monocytes.
    Payne JB; Johnson GK; Reinhardt RA; Dyer JK; Maze CA; Dunning DG
    J Periodontal Res; 1996 Feb; 31(2):99-104. PubMed ID: 8708946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression.
    Horton JK; Williams AS; Smith-Phillips Z; Martin RC; O'Beirne G
    Anal Biochem; 1999 Jun; 271(1):18-28. PubMed ID: 10361000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases.
    Salvi GE; Collins JG; Yalda B; Arnold RR; Lang NP; Offenbacher S
    J Clin Periodontol; 1997 Jan; 24(1):8-16. PubMed ID: 9049792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD14 in periodontitis.
    Nicu EA; Laine ML; Morré SA; Van der Velden U; Loos BG
    Innate Immun; 2009 Apr; 15(2):121-8. PubMed ID: 19318422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of flavonoids on transduction mechanisms in lipopolysaccharide-treated human gingival fibroblasts.
    Gutiérrez-Venegas G; Jiménez-Estrada M; Maldonado S
    Int Immunopharmacol; 2007 Sep; 7(9):1199-210. PubMed ID: 17630199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte activation by Porphyromonas gingivalis LPS in aggressive periodontitis with the use of whole-blood cultures.
    Mahanonda R; Sa-Ard-Iam N; Charatkulangkun O; Promsudthi A; Schifferle RE; Yongvanichit K; Pichyangkul S
    J Dent Res; 2004 Jul; 83(7):540-5. PubMed ID: 15218043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.
    Rams TE; Listgarten MA; Slots J
    J Periodontal Res; 2006 Jun; 41(3):228-34. PubMed ID: 16677293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of Macaca fascicularis against experimental periodontitis using a vaccine containing cysteine proteases purified from Porphyromonas gingivalis.
    Page RC; Lantz MS; Darveau R; Jeffcoat M; Mancl L; Houston L; Braham P; Persson GR
    Oral Microbiol Immunol; 2007 Jun; 22(3):162-8. PubMed ID: 17488441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients.
    Fokkema SJ; Loos BG; Slegte C; van der Velden U
    Clin Exp Immunol; 2002 Feb; 127(2):374-8. PubMed ID: 11876764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus.
    Takahashi K; Nishimura F; Kurihara M; Iwamoto Y; Takashiba S; Miyata T; Murayama Y
    J Int Acad Periodontol; 2001 Oct; 3(4):104-11. PubMed ID: 12666949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue.
    Hosokawa Y; Nakanishi T; Yamaguchi D; Nakae H; Matsuo T
    Clin Exp Immunol; 2005 Mar; 139(3):506-12. PubMed ID: 15730397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.